Nasal immunotherapy in weed-induced allergic rhinitis

Annals of Allergy, Asthma and Immunology

Volumn 79, Issue 3, 1997, Pages 259-265

  Gaglani, Binaca ^a   Borish, Larry ^a   Bartelson, Becki L Bucher ^a   Buchmeier, Andrea ^a   Keller, Lisa ^a   Nelson, Harold S ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CROMOGLYCATE DISODIUM; IMMUNOGLOBULIN G; INTERLEUKIN 10; LORATADINE; SALBUTAMOL;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; FEMALE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; INTRANASAL DRUG ADMINISTRATION; LAVAGE; MALE; NOSE MUCUS; NOSE PROVOCATION TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN TEST; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0030671231     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63012-8     Document Type: Article

References (31)

1. Nickelsen JA, Goldstein S, Mueller U, et al. Local intranasal immunotherapy for ragweed allergic rhinitis. J Allergy Clin Immunol 1981;68:33-40.
2. Welsh PW, Zimmermann EM, Yunginger JW, et al. Preseasonal intranasal immunotherapy with nebulized short ragweed extract. J Allergy Clin Immunol 1981;67:237-42.
3. Georgitis JW, Nickeisen JA, Wypych JI, et al. Local intranasal immunotherapy with high dose polymerized ragweed extract. Int Arch Allergy Appl Immunol 1986;81:170-3.
4. Andri L, Sannam G, Betteli C, et al. Local nasal immunotherapy with extract in powder form is effective and safe in grass pollens rhinitis. A double blind study. J Allergy Clin Immunol 1996;97:34-41.
5. Passalacqua G, Albano M, Rufoni S, et al. Nasal immunotherapy to Parietaria: evidence of reduction of local allergic inflammation. Am J Respir Crit Care Med 1995;152:461-6.
6. Andri L, Senna GE, Beteli C, et al. Local nasal immunotherapy for Dermatophagoides induced rhinitis: efficacy of a powder extract. J Allergy Clin Immunology 1993;91:987-96.
7. Bousquet J, Lebel B, Dhivert H, et al. Nasal challenge with pollen grains, skin-prick tests and specific IgE in patients with grass pollen allergy. Clin Allergy 1987;17:529-36.
8. Duffy JP, Smith PJ, Crocker J, Matthews HR. Combined staining method for the demonstration of tissue eosinophils and mast cells. Histotechnol 1993;Vol. (2).
9. Snedecor G, Cochran W. Statistical Methods, 8th Ed, Iowa State University Press, Ames, 1989.
10. SAS Institute Inc., SAS Technical Report P-229, SAS/STAT Software: Changes and Enhancements, Release 6.07, Gary, NC:SAS Institute Inc., 1992.
11. Andri L, Senna GE, Betelli C, et al. Local nasal immunotherapy in allergic rhinitis to Parietaria. Allergy 1992;47:318-23.
12. Moller C, Dreborg S, Lanner A, Bjorksten B. Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen. Allergy 1986;41:271-9.
13. Taudorf E, Laursen L, Lanner A, et al. Specific IgE, IgG, and IgA antibody response to oral immunotherapy in birch pollinosis. J Allergy Clin Immunol 1989;83:589-94.
14. Oppenheimer J, Areson JG, Nelson HS. Safety and efficacy of oral immunotherapy with standardized cat. J Allergy Clin Immunol 1994;93:61-7.
15. Secrist H, Chelen CJ, Wen Y, et al. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 1993;178:2123-30.
16. Briner TJ, Kuo M-, Keating KM, et al. Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen. Proc Natl Acad Sci USA 1993;90:7608-12.
17. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-95.
18. Malefyt RD, Yssel H, de Vries JE. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells: specific inhibition of IL-2 production and proliferation. J Immunol 1993;150:4754-5765.
19. Del Prete G, De Carli M, Almerigogna F, et al. Human IL-10 is produced by both type 1 helper (Th1) and Type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993;150:353-60.
20. Malefyt R, Abrams J, Bennett B, et al. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an auto-regulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
21. Fiorentino DF, Zlotni A, Mosmann TR, et al. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
22. Ralph P, Nakoinz I, Sampson-Johannes A, et al. IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol 1992;148:808-14.
23. D'Andrea A, Aste-Amezaga M, Vaiante NM, et al. Interleukin 10 (IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993;178:1041-8.
24. Malefyt RD, Haanen J, Spits H, Roncarolo MG. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down regulation of class II major histocompatibility complex expression. J Exp Med 1991;174:915.
25. Ding L, Linsley PS, Huang L, et al. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993;151:1224-34.
26. Punnonen J, Malefyt RD, Van Vlasselaer P, et al. IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes. J Immunol 1993;151:1280-9.
27. Takanaski S, Nonaka R, Xing Z, et al. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J Exp Med 1994;180:711-5.
28. Enk AH, Angeloni VL, Udey MC, Katz SI. Inhibition of Langerhans cell antigen-presenting function by IL-10: A role for IL-10 in induction of tolerance. J Immunol 1993;151:2390-8.
29. Becker JC, Czerny C, Brocker E-B. Maintenance of clonal anergy by endogenously produced IL-10. Int Immunol 1994;6:1605-12.
30. Borish L, Aarons A, Rumbyrt J, et al. Interleukin-10 regulation in normal and asthmatic subjects. J Allergy Clin Immunol 1996;97:1288-96.
31. Briere F, Servet-Delprat C, Bridon J-M, et al. Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3. J Exp Med 1994;179:757-62.